Tau is a microtubule-associated protein exerting several physiological functions in neurons. In Alzheimer's disease (AD) misfolded tau accumulates intraneuronally and leads to axonal degeneration.
| I N T R O D U C T I O N
The amyloid hypothesis has dominated the field of Alzheimer's disease (AD) pathogenesis in the last 30 years. However, increasing evidence demonstrates the pivotal role of tau protein in this pathology (Guerrero-Munoz, M.J., Gerson J., Castillo-Carranza, D.L., 2015) . Tau is a microtubule-associated protein primarily localized in the axons of neurons and its main physiological role is to stabilize microtubules.
However, many other functions have been identified for this protein that include axonal transport, signal transduction, and neuronal polarization (Medina & Avila, 2014) . Six tau isoforms are derived from alternative splicing of the microtubule-associated protein tau (MAPT) gene transcript in the adult brain, with the 4R/2N isoform being the longest one Kampers, Pangalos, Geerts, Wiech, & Mandelkow, 1999) . Tau protein is highly subjected to phosphorylation and in several pathologies, including AD, hyperphosphorylated, and misfolded tau accumulates intraneuronally and leads to axonal degeneration, thus contributing to neuronal loss.
Although tau is an intracellular protein, full-length tau have also been found in the extracellular medium, mainly due to activitydependent secretion from neurons and/or release from dead cells Medina & Avila, 2014; Pooler, Phillips, Lau, Noble, & Hanger, 2013; Yamada et al., 2014) . Recent studies suggested that soluble extracellular tau aggregates impinge on the synaptic function Guerrero-Muñoz et al., 2015; Lasagna-Reeves et al., 2011) . We recently demonstrated that extracellular application of oligomeric tau (ex-oTau) inhibited synaptic plasticity at the CA3-CA1 synapses and impaired limbic system-dependent memory formation in mice (F a et al., 2016) . We also found that the synaptotoxic tau oligomers crossed plasma membranes of cultured hippocampal neurons and accumulated intracellularly whereas tau monomers, that did not exert any adverse effect on brain functions, are less prone to enter neurons *These authors contributed equally to this work. Wu et al., 2013) , though they enter SH-SY5Y neuroblastoma cells (Michel et al., 2013) where they may exert a toxic action mediated by M1 and M3 muscarinic receptors activation (Díaz-Hern andez et al., 2010) .
In tauopathies, tau accumulation has also been found in cells others than neurons, that is, astrocytes and microglia (Asai et al., 2015; Bol os et al., 2016; Forman et al., 2005; Kahlson & Colodner, 2016; Lasagna-Reeves et al., 2014; Maphis et al., 2015; Togo & Dickson, 2002) . The role of microglia in tau pathology has been extensively investigated (Asai et al., 2015; Bol os et al., 2016; Luo et al., 2015; Maphis et al., 2015) , whereas that of astrocytes remains unclear yet. In particular, so far no studies have addressed the role of astrocytes in tau-induced synaptic dysfunction. Astrocytes have several functions in the brain: besides providing structural and metabolic support to neurons, they directly modulate a number of neuronal functions (Giaume & Oliet, 2016) . Specifically, they modulate synaptic transmission (Araque, Sanzgiri, Parpura, & Haydon, 1998; Fields & Burnstock 2006; Jourdain et al., 2007; Perea & Araque, 2010; Zorec, Parpura, Vardjan, & Verkhratsky, 2016a) and orchestrate synaptic plasticity (De Pitt a, Brunel, & Volterra, 2016) . Astrocytes are indeed partner in the "tripartite synapse": they exchange information with the synaptic neuronal elements, respond to synaptic activity and regulate synaptic transmission through the Ca 21 -dependent release of gliotransmitters such as ATP, glutamate and Dserine (Fields & Burnstock, 2006; Zorec et al., 2016a) . Therefore astrocytes are also actively involved in memory formation, and they may play a key role in neurodegenerative diseases (Gao et al., 2016; Verkhratsky, Zorec, Rodriguez, & Parpura, 2016; Zorec, Parpura, Vardjan, & Verkhratsky, 2016b ).
Here, we tested the hypothesis that accumulation of tau oligomers in astrocytes contributed to tau-induced synaptic dysfunction by impinging on gliotransmitter release.
| MATERIALS A ND METHODS

| Primary cultures of hippocampal neurons and astrocytes
Co-cultures of hippocampal neurons and astrocytes were obtained from wild type (WT) E18 C57/bl6 mice as previously described (Maiti, Piacentini, Ripoli, Grassi, & Bitan, 2011) with minor modifications. Primary cultures of cortical and/or hippocampal astrocytes were obtained from E18 C57/bl6 mice, CByJ.B6-Tg(CAG-EGFP) 1Osb/J (eGFP expressing mice) and B6.129S7-Apptm1Dbo/J (APP KO) mice as previously described (Podda et al., 2012) . Briefly, after removing brain, dissected cortices were incubated for 10 min at 378C in phosphate buffered saline (PBS) containing trypsin-ethylenediaminetetraacetic acid (0.025%/0.01% w/v; Biochrom AG, Berlin, Germany) and the tissue was mechanically dissociated at room temperature [(RT), 23-258C] with a fire-polished Pasteur pipette. The cell suspension was harvested and centrifuged at 235 3 g for 8 min.
Then, for co-cultures of neurons and astrocytes, the pellet was suspended in 88.8% minimum essential medium (MEM, Biochrom), 5% fetal bovine serum (FBS), 5% horse serum, 1% glutamine (2 mM), 1% Turin, Italy) as previously described (F a et al., 2016) . Briefly, tau solutions (2 mM in PBS) were mixed with 6 mM IRIS 5 in dimethyl sulfoxide for 4 h in the dark under mild shaking conditions. After this time, labeled tau was purified with Vivacon 500 ultrafiltration spin columns (Sartorius Stedim Biotech GmbH, Goettingen, Germany) and then resuspended in PBS and used at final concentration of 100 nM. Immunocytochemistry and confocal microscopy were performed in cells treated with IRIS 5-labeled oligomeric tau for either 1 or 7 h. All experiments were repeated at least three times. To quantify the amount of cellular internalization of tau, the parameter "internalization index" was introduced by multiplying the percentage of astrocytes or neurons internalizing fluorescent proteins in each analyzed microscopic field by the mean number of fluorescent spots inside cells.
| Confocal Ca 21 imaging
Confocal Ca 21 imaging was performed as previously described (Iacopino et al., 2014; Santoro et al., 2014) 
| High performance liquid chromatography (HPLC) measurements
For HPLC measurements astrocytes were cultured in 30-mm wells and treated for 1 hour with tau or vehicle in Tyrode's solution. At the end of treatment tau-or vehicle-containing Tyrode's solution was withdrawn from each well and samples were deproteinized as described in details elsewhere (Tavazzi et al., 2005) . Briefly, samples were transferred to an Eppendorf tube equipped with a filtering membrane of 3KDa cut-off (Nanosep® Centrifugal Devices, Pall Gelman Laboratory, Ann Arbor, MI, USA) and centrifuged at 10,500 3 g for 30 min at 48C.
The protein-free ultrafiltrate fluids were directly injected onto the HPLC column and analyzed to determine concentrations of ATP, ADP, glutamate (Glu), glutamine (Gln), and serines (Ser, both L-and D-). The two nucleotides were separated and quantified according to an ionpairing HPLC method previously set up (Tavazzi et al., 2005) , whilst the amino acids were analyzed as ortophtalaldehyde (OPA) derivatives using a different method with pre-column derivatization (Amorini et al., 2012 (Amorini et al., , 2016 
| Whole-cell patch-clamp recordings
Electrophysiological recordings were carried out as described in Ripoli et al. (2013) and (2014) software (Molecular Devices, Sunnyvale, CA). After establishing a gigaseal, the cell membrane was ruptured to establish the whole-cell configuration, then at least 3 min were allowed for patch stabilization and cytosol dialysis. The membrane potential was voltage-clamped at 270 mV and miniature excitatory postsynaptic currents (mEPSCs) were recorded in 60-s epochs. All electrophysiological recordings were analyzed using the Clampfit 10.6 software (Molecular Devices). For mEPSC frequency analysis, a template was constructed using the "Event detection/create template" function, as previously described in Ripoli et al. (2013) . Then, mEPSCs were detected using the "Event detection/template search" function; the "template match threshold" was set to 3.5 and the result inspected for false positives. For mEPSC amplitude analysis, all the waveforms detected during a single recording using template analysis were averaged and the corresponding amplitude calculated.
| Immunocytochemistry
Immunocytochemistry was performed as previously described (Ripoli et al., 2013; Piacentini et al., 2015) . 
| Hippocampal slice cultures and immunohistochemistry
Hippocampal organotypic slice (350 lm) cultures were prepared from postnatal day 4-7 Wistar rats through a McIllwain tissue chopper as described in Bosch et al. (2014) . Cutting solution contained the following (in mM): 2.5 KCl, 25.6 NaHCO 3 , 1.15 NaHPO 4 , 11 D-glucose, 238
Sucrose, 1 CaCl 2 , and 5 MgCl 2 . Slices were cultured at 358C on interface membranes (Millipore) and fed with MEM media containing 20% horse serum (GIBCO), 27 mM D-glucose, 6 mM NaHCO 3 , 1 mM CaCl 2 , 1 mM MgSO 4 , 30 mM HEPES, 0.01% ascorbic acid, and 1 mg/ml insulin. pH was adjusted to 7.3 and osmolality to 300-320 mOsm. Medium was changed every 48 h. After 10-day culture organotypic slice were treated with 100 nM of fluorescent IRIS-5 labeled oTau for 1 h and then fixed overnight at 48C with paraformaldehyde (4% in PBS). The following day slices were incubated with blocking buffer containing PBS with 3% normal goat serum (NGS, Sigma) and 2% Triton-X 100 for 2 h at RT. The following day, slices were treated with one of the following primary antibodies 
| Western blot
Western blot experiments were carried out as previously described (Piacentini et al., 2015; Ripoli et al., 2013 
| FM1-43 imaging
FM1-43 imaging was performed as described (Gaffield & Betz, 2006) , with some modification. Briefly, culture medium of mouse hippocampal 
| Statistics
Statistical comparisons were performed with Systat 10.2 software. All data were expressed as mean 6 standard error of the mean (SEM) and followed normal distribution, as assessed by the same software. In order to assess whether tau treatment significantly affected the measured parameters, the two-tailed Student's t test was used. One-way ANOVA with Student-Newman-Keuls's (SNK) post hoc test was used for multiple comparisons. For experiments that included fewer than 10 observations (e.g., densitometric analysis of western blotting data), or for non-normally distributed data, the Mann-Whitney (Wilcoxon) statistic was used. The level of significance was set at 0.05.
In all experiments the operators were blind to the study conditions. We quantified the intracellular accumulation of ex-oTau in the two cellular populations of our culture, that is, MAP2-positive and GFAPpositive cells. We found that 96 6 3% of astrocytes (n 5 71 cells analyzed in 14 fields) and 85 6 6% of the neurons (n 5 41 cells in 14 microscopic fields) exhibited tau accumulation. Notably, the mean number of intracellular fluorescent spots was significantly higher in astrocytes (11.3 6 1.0) than in neurons (2.5 6 0.3). To provide an overall estimate of the protein uploading from these two cell populations we defined the "internalization index" (see "Methods") that was 12.6 6 1.9
| Ethics statement
for astrocytes and 2.5 6 0.5 for neurons (p 5 5.14 3 10 25 assessed by Student's t test; t 5 24.9, dof 5 25; Figure 1D ). We also validated our Collectively, these data indicate that astrocytes exhibit much greater avidity for tau than neurons. Based on these results, shortlasting (i.e., 1-h) ex-oTau treatments of hippocampal neuron and astrocyte co-cultures were used in subsequent experiments to determine the specific contribution of astrocytes to tau-induced synaptic dysfunction.
| Tau treatment affects intracellular Ca 21 signals in cultured astrocytes
We then analyzed the functional alterations induced by ex-oTau internalization in astrocytes. Astrocyte functions are primarily regulated by intracellular Ca 21 transients (Scemes & Giaume, 2006 respect to vehicle-treated cultures (from 93 6 27 to 28 6 13 nM; p 5 .0053 assessed by Mann-Whitney test, n 5 5 replicates), whereas glutamate, glutamine and serine (both L-and D-) were reduced by 52 6 5% (from 0.91 6 0.14 to 0.45 6 0.11 mM), 61 6 14% (from 33.6 6 8.4
to 12.2 6 4.5 mM) and 55 6 2% (from 15.2 6 0.8 to 6.2 6 0.5 mM), respectively (p 5 .036 for each comparison). Conversely, ADP levels increased following tau treatment (128 6 13%; p 5 .036; Fig. 3 ). reduced by 59 6 7, 45 6 7, and 27 6 1%, respectively (p 5 .037 vs.
vehicle assessed by Mann-Whitney test, n 5 3 replicates; Figure 4d ,e). (Swanson & Graham, 1994) . Notably, fluorocitrate inhibits astrocytes without directly affecting neurons. We found that application of FC (100 mM) for 1.5 h altered basal synaptic transmission and synaptic protein expression similarly to ex-oTau (Supporting Information Figure 5 ). In fact, ANOVA test revealed significant differences between vehicle-and FC-treated neurons in terms of fre- 3.5 | APP is necessary for tau internalization in astrocytes and changes in intracellular Ca 21 signaling and gliotransmitter release
To validate the role of astrocytes in the synaptotoxic action of tau we investigated the effects of ex-oTau in hippocampal neurons plated onto astrocytes that are unable to upload tau from the extracellular medium. Previous studies demonstrated that internalization of extracellular tau depended on its interaction and binding with heparan sulfate proteoglycans (HSPG) (Holmes et al., 2013; Mirbaha, Holmes, Sanders, Bieschke, & Diamond, 2015) . It is also known that APP and HSPG likely interact at the plasma membrane (Reinhard, Borgers, David, & De Strooper, 2013) and in the absence of proteins belonging to the APP superfamily HSPG are rapidly degraded (Cappai et al., 2005) . Moreover, 
| DISCUSSION
In this study, we demonstrated that extracellular application of both recombinant oligomeric tau and tau isolated from brains of AD patients depresses synaptic transmission in vitro through a mechanism directly involving the impairment of gliotransmitter release from astrocytes.
Both astrocytes and neurons are targets of extracellular tau oligomers but, at least in the very early phases of tau exposure, astrocytes uploaded tau more rapidly and abundantly than neurons. After 1-h exposure the accumulation of tau in neurons was very scarce and it became evident only after several hours of treatment (F a et al., 2016 ).
Therefore we used this experimental model (i.e., short-lasting tau treatments) to identify the specific contribution of astrocytes to the tauinduced synaptic dysfunction. Following 1-h exposure to ex-oTau hippocampal neurons co-cultured with astrocytes exhibited: (i) reduced levels of presynaptic and postsynaptic proteins (synapsin-1, synaptophysin, and GluR1); (ii) a significant decrease of evoked vesicular release; and (iii) a significant reduction of mEPSC frequency and amplitude. These findings suggest that tau-accumulating astrocytes significantly contribute to the synaptic depression induced by oTau.
It is known that astrocytes strongly affect synaptic transmission through Ca
21
-dependent release of a plethora of gliotransmitters that include glutamate, D-serine, and ATP (Araque et al., 1998; Fields & Burnstock, 2006; Jourdain et al., 2007; Perea & Araque, 2010; Zorec et al., 2016a) . Calcium-dependent release of gliotransmitters have been proposed for uptake of extracellular fibrils (Takahashi et al., 2015) ;
or ii) it may affect HPSG expression (Cappai et al., 2005; Reinhard et al., 2013 ) that has been also demonstrated to be necessary for tau internalization in neurons (Holmes et al., 2013; Mirbaha et al., 2015) .
In conclusion, our data demonstrate that astrocytes significantly contribute to the synaptotoxic action of oTau likely cooperating with the direct action exerted by this misfolded protein in neurons (F a et al., 2016) . Tau | 1313 vesicular release thus leading to a reduction of synaptic protein expression and a depressed transmission in the neighboring neurons. In vivo, the scenario is more complex than that analyzed in our experimental models because of brain mechanisms other than purinergic signals (e.g., adrenergic signals) modulating glial function and glial-to-neuron communication in response to stressful and/or pathological stimuli (Braun, Madrigal, & Feinstein, 2014; Franke, Verkhratsky, Burnstock, & Illes, 2014) . Nonetheless, our findings unveil the critical role played by altered gliotransmission in the tau-induced synaptic deficits thus contributing to advance our understanding of the cellular and molecular mechanisms underlying progressive cognitive decline and memory loss in tauopathies, including AD, caused by accumulation of misfolded tau protein in the brain.
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